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consumption to find any significant difference.METHODS:A total of 161 antibiotics
are in Iran’s drugs list. According to Iran’s FDO regulations all pharmaceutical
companies should report their sales statistics to this organization each month.
Sales amount could be derived from this database state by state. According toWHO
method, each drug ATC and DDD code have been derived. DID index (Defined daily
dose /1000 Inhabitants/ Day) have been calculated according to the population of
each states. RESULTS: Correlation coefficients of ascending trends of antibiotics in
Northern states’ and Iran have been reported respectively as following: In oral
antibiotics, four classes have significant ascending trend: Betalactams (0.715 vs.
0.693), Cephalosporines (0.99 vs. 0.989), Macrolides (0.911 vs. 0.949), Quinolones
(0.897 vs. 0.9). Three classes have significant descending trend: Amphenicoles
(-0.836 vs. -0.76), Sulfonamides (- 0.924 vs. -0.948), Aminoglycosides (-0.809 vs.
-0.943). In parenteral antibiotics two classes have significant ascending trend: Imi-
penem (0.967 vs. 0.979), Macrolides (0.951 vs. 0.95). Two of them have significant
descending trend: Betalactams (- 0.916 vs. -0.79), Aminoglycosides (-0.809 vs.
-0.943). CONCLUSIONS: Most trends were ascending and same as the pattern of
whole countries consumption. These results approve the theory of the priority in
training programs to clinicians and people according to RUD’s goals in Northern
states’ same as other parts of country.
PHP26
CONSUMPTION OF ANTIDIABETICS IN SERBIA IN 2010: A COMPARISON WITH
CROATIA AND DENMARK
Pavlovic´ N1, Stanimirov B1, Stojancˇevic´ M1, Paut Kusturica M1, Sabo A2, Tomic´ Z1, Mikov
M1
1University of Novi Sad, Medical Faculty, Novi Sad, Serbia and Montenegro, 2Faculty of Medicine,
University of Novi Sad, Novi Sad, Vojvodina, Serbia and Montenegro
OBJECTIVES: Considering diabetes as a major public health problem worldwide,
the aim of our study was to analyze overall volume of use of antidiabetics, com-
pared to Croatia, as the neighboring country, and Denmark, chosen for its rational
and conservative prescription practice. METHODS: Data for consumption of anti-
hyperglycaemic drugs (A10) in 2010 were obtained by a retrospective, observa-
tional, population-based study. Utilization of these drugs was expressed as DDD
per 1000 inhabitants a day (DID). RESULTS: In 2010, antidiabetics (A10) were used at
a similar rate in Serbia, Croatia and Denmark (47.34 DID, 49.88 DID and 47.50 DID,
respectively), but the share of utilization of insulins (A10A) and oral antidiabetics
(A10B) differed between countries. Relatively high proportion of insulin use in Den-
mark (36.2% of all antidiabetics) compared to Serbia (22.0%) and Croatia (26.4%)
may be attributed to high incidence of type 1 diabetes in Nordic countries and
compliance with most of recent pharmacotherapeutic guidelines that suggest the
use of long-acting insulins (A10AE) in type 2 diabetes (4.0 DID of A10AE inDenmark,
in comparison to 1.28 DID in Serbia and 1.91 DID in Croatia). Proportions of oral
antidiabetics use also differed between these countries. Metformin, as the only
biguanide (A10BA) used and preferred oral agent for type 2 diabetes, accounted for
51.2% of total use of oral antidiabetics in 2010 in Denmark, while sulfonylureas
(A10BB), as a second-line treatment, were used at a rate of 36.6%. In Serbia and
Croatia, sulfonylureas were used predominantly (55.6% and 48.6, respectively).
New medicinal products with effect on the incretin system (A10BH and A10BX)
were used at a rate of 4.1 DID in Denmark, contrary to 0.45 DID in Croatia and 0.002
DID in Serbia. CONCLUSIONS: The large differences in utilization of various an-
tidiabetics between observed countries suggest considerable variations in habits,
especially with regard to type 2 diabetes treatment.
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OBJECTIVES: To explore the effect of retirement on retiree’s mental health, this
study investigated the change in the usage of sedative-hypnotic drugs after the
retirement for sedative-hypnotic users. METHODS: We conducted a retrospective
cohort study with comparison groups through following a population-based ran-
dom sample containing one-million beneficiaries of Taiwan’s National Health In-
surance from 1999 to 2009. Individuals retired between 2000 and 2003 and aged
between 50 and 64 were first identified. Those taking sedative-hypnotic drugs at
least one year before and six years after retirement were selected as the study
sample, and were further stratified into high-dosage and low-dosage users based
on their defined daily doses (DDDs). A propensity score (PS) matching was con-
ducted to select two non-retiree control groups with respect to sedative-hypnotic
dosage. Each non-retiree was assigned a pseudo retirement date, the same retire-
ment date as his/her matching retiree counterpart. Nonparametric Wilcoxon tests
were conducted to compare the differences in DDDs between the retiree and con-
trol groups. Generalized estimating equations (GEE) were employed to investigate
the odds ratios (ORs) of drug usage between the retiree and control groups.
RESULTS: 9,687 retired sedative-hypnotic users were identified. After PSmatching,
the number of high-dosage users in both retiree and control groups was 3,265, and
the number of low-dosage users was 3,072. The Wilcoxon tests revealed no differ-
ence in DDDs between the retirees and non-retirees before and after their retire-
ments. The GEE analyses however showed that, compared to their non-retiree
counterparts, the low-dosage retired users significantly reduced the dosage of after
their retirement (OR0.97, p  0.05). A similar trend was observed in the high-
dosage users but no significance. CONCLUSIONS: The decrease in the dependence
on sedative-hypnotic drugs after their retirements for low-dosage usersmight sug-
gest the retirement had a positive influence on mental health.
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OBJECTIVES: To systematically identify the main factors those contribute towards
the increase of pharmaceutical expenditures. METHODS: A systematic search of
published studies was conducted in common major electronic databases using
search terms “factors’’, ‘‘financing ’’, ‘‘pharmaceutical’’, and ‘‘expenditures’’. To be
included the studies need to 1) measure at least one of the following outcomes:
total growth in pharmaceutical expenditures, price growth quantity growth; 2) A
clear method to analyze the impact of factors affecting the increases of drug ex-
penditures was mentioned; 3) were written in English. Non-primary articles that
were published only as abstract, review; commentary and letter were excluded.
Data were extracted from the primary eligible studies using data abstraction form.
Information regarding study title, study author (s), country, year, study objective,
study design, statisticalmethods to assess factors affecting pharmaceutical expen-
ditures, results, and author (s) conclusionswere collected.RESULTS: Froma total of
2039 studies, only 20 studies were included for full review. The most significant
determinants or factors of drug spending are demographic, disease category, pub-
lic health, price, utilization, therapeutic choice, and residual –productmix. A num-
ber of studies from the review indicate that residual –product mix responsible for
between approximately 30 per cent to approximately 493 per cent of total increases
drug expenditures. CONCLUSIONS: Price change has little effect on expenditure
increases compared with utilization and the residual. All the above factors need to
be considered for optimum drug policy design. It is most important for policy
makers to understand pharmaceutical spending trends, the factor influencing the
rising of the limited resources and the main cost containment strategies.
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OBJECTIVES:Depressive disorder is one of themajor public health problems due to
significant disability that it causes, aswell difficulties in diagnostic procedures. The
aim of the study was to determine the total antidepressant utilization in Serbia in
correlation with Denmark and to get insight into financial resources allocations.
Denmark was chosen for its developed pharmacotherapeutic practice.METHODS:
Data for antidepressant (ATC group N06) utilization and consumption of financial
resources in 2010 were retrieved from the annual reports of relevent public insti-
tutions. The ATC/DDD methodology was applied and results were expressed in
defined daily doses (DDDs) per 1000 inhabitants per day (DID). RESULTS: An inter-
esting result of our study is that the utilization of antidepressants in 2010 appeared
to be 7-fold higher in Denmark (83.8 DID) than in our country (11.67 DID). In accor-
dancewith these results, the consumption of financial resources for groupN06was
approximately 9-fold higher inDenmark (89.680.072USD) than in Serbia (10.261.963
USD). The most commonly used group of antidepressants in both countries were
selective serotonine reuptake inhibitors (SSRI) (67.3% and 73.76% of all antidepres-
sants for Denmark and Serbia respectively) which complies with the most recent
clinical guidelines. There was a considerable difference between Denmark and
Serbia in the utilization of a group N06AX which includes new generation of anti-
depressants (22.7 DID and 1.39 DID respectively). CONCLUSIONS: The differences
between selected countries in antidepressant utilization and consumption of fi-
nancial resources are partly consequential to different socioeconomic and health
policy factors. This study shows that the overall utilization of antidepressants in
Serbia is lower than in Denmark, which implies possible underdiagnosing of affec-
tive disorders in general practice.
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OBJECTIVES: To analyze the current utilization and expenditure of reimbursed
digestive enzyme agents (DEs) in Taiwan. METHODS: The encrypted claim data-
base of National Health Insurance (NHI) was used to analyze the prescription pat-
terns and the expenditure of DEs for types of diseases, health care specialties,
levels of medical institution, and insured BNHI branch. RESULTS: We identified
that 29DEs,within 15 groupings, are reimbursed byNHI up to 2011. Given thatmost
DEs were developed in earlier stage, while only 2 items were approved by the
Taiwan Food and Drug Administration after 2000, these approved items had
broader scope of approved indications and limited evidence on their clinical effi-
cacy. According to the analysis of 2001-2010 NHI databases, the most enzymes
prescribed disease was gastroenteritis, related uncomfortable symptoms, and so
forth. Over the ten years, the number of medical orders increased from 22.77 mil-
lion to 46.71 million. Medical costs increased from more than NT$ 1 hundred mil-
lion to over NT$ 2 hundred million. The highest usage rate of medical orders, by
specialties, is 64% in Internal Medicine, especially in Gastroenterology and in Gen-
eral Medicine. The second is 7% to 9.6 % in Family Medicine. The usage rate is
increasing each year in Surgery, from 4.13% in 2011 to 9.27% in 2010. The usage
rates of medical order by 15 groupings have various trends of levels between dif-
ferent medical institution, and different insured BNHI branch. CONCLUSIONS:
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